BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16932414)

  • 1. Obstructive nephropathy: towards biomarker discovery and gene therapy.
    Chevalier RL
    Nat Clin Pract Nephrol; 2006 Mar; 2(3):157-68. PubMed ID: 16932414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical-molecular markers in unilateral ureteral obstruction.
    Manucha W
    Biocell; 2007; 31(1):1-12. PubMed ID: 17665634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of obstructive nephropathy in the newborn.
    Chevalier RL
    Semin Nephrol; 1998 Nov; 18(6):585-93. PubMed ID: 9819149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of congenital obstructive nephropathy: past, present and future.
    Chevalier RL
    J Urol; 2004 Sep; 172(3):852-7. PubMed ID: 15310982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression in chronic kidney disease.
    Eddy AA
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):353-65. PubMed ID: 16198274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstructive uropathy.
    Truong LD; Gaber L; Eknoyan G
    Contrib Nephrol; 2011; 169():311-326. PubMed ID: 21252529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in epithelial-mesenchymal transition: a new insight into obstructive nephropathy.
    Bani-Hani AH; Campbell MT; Meldrum DR; Meldrum KK
    J Urol; 2008 Aug; 180(2):461-8. PubMed ID: 18550128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction.
    Kellner D; Chen J; Richardson I; Seshan SV; El Chaar M; Vaughan ED; Poppas D; Felsen D
    J Urol; 2006 Aug; 176(2):806-12. PubMed ID: 16813952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
    Guarino M; Tosoni A; Nebuloni M
    Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell apoptosis and proliferation in obstructive uropathy.
    Truong LD; Sheikh-Hamad D; Chakraborty S; Suki WN
    Semin Nephrol; 1998 Nov; 18(6):641-51. PubMed ID: 9819155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and cellular pathophysiology of obstructive nephropathy.
    Chevalier RL
    Pediatr Nephrol; 1999 Sep; 13(7):612-9. PubMed ID: 10460514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital ureteropelvic junction obstruction: physiopathology, decoupling of tout court pelvic dilatation-obstruction semantic connection, biomarkers to predict renal damage evolution.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):213-9. PubMed ID: 22428472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mediators and growth factors in obstructive renal injury.
    Misseri R; Rink RC; Meldrum DR; Meldrum KK
    J Surg Res; 2004 Jun; 119(2):149-59. PubMed ID: 15145697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of interstitial fibrosis in obstructive nephropathy.
    Diamond JR; Ricardo SD; Klahr S
    Semin Nephrol; 1998 Nov; 18(6):594-602. PubMed ID: 9819150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis.
    Ma FY; Flanc RS; Tesch GH; Han Y; Atkins RC; Bennett BL; Friedman GC; Fan JH; Nikolic-Paterson DJ
    J Am Soc Nephrol; 2007 Feb; 18(2):472-84. PubMed ID: 17202416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of growth factors, cytokines, and vasoactive compounds in obstructive nephropathy.
    Klahr S; Morrissey JJ
    Semin Nephrol; 1998 Nov; 18(6):622-32. PubMed ID: 9819153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary tract obstruction.
    Klahr S
    Semin Nephrol; 2001 Mar; 21(2):133-45. PubMed ID: 11245776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin attenuates renal fibrosis and inflammation of obstructive nephropathy.
    Sun GX; Ding R; Li M; Guo Y; Fan LP; Yue LS; Li LY; Zhao M
    J Urol; 2015 Jun; 193(6):2107-15. PubMed ID: 25481038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinase domain of death-associated protein kinase is inhibitory for tubulointerstitial fibrosis in chronic obstructive nephropathy.
    Yukawa K; Kishino M; Hoshino K; Shirasawa N; Kimura A; Tsubota Y; Owada-Makabe K; Bai T; Tanaka T; Ueyama T; Ichinose M; Takeda K; Akira S; Maeda M
    Int J Mol Med; 2005 Jan; 15(1):73-8. PubMed ID: 15583830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal damage inhibited in mice lacking angiotensinogen gene subjected to unilateral ureteral obstruction.
    Uchida Y; Miyajima A; Kikuchi E; Kozakai N; Kosaka T; Ieda M; Fukuda K; Ohigashi T; Oya M
    Urology; 2009 Oct; 74(4):938-43. PubMed ID: 19428059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.